Cargando…

IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity

BACKGROUND: Interferon induced transmembrane proteins 1, 2 and 3 (IFITMs) belong to a family of highly related antiviral factors that have been shown to interfere with a large spectrum of viruses including Filoviruses, Coronaviruses, Influenza virus, Dengue virus and HIV-1. In all these cases, the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Tartour, Kevin, Appourchaux, Romain, Gaillard, Julien, Nguyen, Xuan-Nhi, Durand, Stéphanie, Turpin, Jocelyn, Beaumont, Elodie, Roch, Emmanuelle, Berger, Gregory, Mahieux, Renaud, Brand, Denys, Roingeard, Philippe, Cimarelli, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251951/
https://www.ncbi.nlm.nih.gov/pubmed/25422070
http://dx.doi.org/10.1186/s12977-014-0103-y
_version_ 1782347123085279232
author Tartour, Kevin
Appourchaux, Romain
Gaillard, Julien
Nguyen, Xuan-Nhi
Durand, Stéphanie
Turpin, Jocelyn
Beaumont, Elodie
Roch, Emmanuelle
Berger, Gregory
Mahieux, Renaud
Brand, Denys
Roingeard, Philippe
Cimarelli, Andrea
author_facet Tartour, Kevin
Appourchaux, Romain
Gaillard, Julien
Nguyen, Xuan-Nhi
Durand, Stéphanie
Turpin, Jocelyn
Beaumont, Elodie
Roch, Emmanuelle
Berger, Gregory
Mahieux, Renaud
Brand, Denys
Roingeard, Philippe
Cimarelli, Andrea
author_sort Tartour, Kevin
collection PubMed
description BACKGROUND: Interferon induced transmembrane proteins 1, 2 and 3 (IFITMs) belong to a family of highly related antiviral factors that have been shown to interfere with a large spectrum of viruses including Filoviruses, Coronaviruses, Influenza virus, Dengue virus and HIV-1. In all these cases, the reported mechanism of antiviral inhibition indicates that the pool of IFITM proteins present in target cells blocks incoming viral particles in endosomal vesicles where they are subsequently degraded. RESULTS: In this study, we describe an additional mechanism through which IFITMs block HIV-1. In virus-producing cells, IFITMs coalesce with forming virions and are incorporated into viral particles. Expression of IFITMs during virion assembly leads to the production of virion particles of decreased infectivity that are mostly affected during entry in target cells. This mechanism of inhibition is exerted against different retroviruses and does not seem to be dependent on the type of Envelope present on retroviral particles. CONCLUSIONS: The results described here identify a novel mechanism through which IFITMs affect HIV-1 infectivity during the late phases of the viral life cycle. Put in the context of data obtained by other laboratories, these results indicate that IFITMs can target HIV at two distinct moments of its life cycle, in target cells as well as in virus-producing cells. These results raise the possibility that IFITMs could similarly affect distinct steps of the life cycle of a number of other viruses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12977-014-0103-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4251951
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42519512014-12-03 IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity Tartour, Kevin Appourchaux, Romain Gaillard, Julien Nguyen, Xuan-Nhi Durand, Stéphanie Turpin, Jocelyn Beaumont, Elodie Roch, Emmanuelle Berger, Gregory Mahieux, Renaud Brand, Denys Roingeard, Philippe Cimarelli, Andrea Retrovirology Research BACKGROUND: Interferon induced transmembrane proteins 1, 2 and 3 (IFITMs) belong to a family of highly related antiviral factors that have been shown to interfere with a large spectrum of viruses including Filoviruses, Coronaviruses, Influenza virus, Dengue virus and HIV-1. In all these cases, the reported mechanism of antiviral inhibition indicates that the pool of IFITM proteins present in target cells blocks incoming viral particles in endosomal vesicles where they are subsequently degraded. RESULTS: In this study, we describe an additional mechanism through which IFITMs block HIV-1. In virus-producing cells, IFITMs coalesce with forming virions and are incorporated into viral particles. Expression of IFITMs during virion assembly leads to the production of virion particles of decreased infectivity that are mostly affected during entry in target cells. This mechanism of inhibition is exerted against different retroviruses and does not seem to be dependent on the type of Envelope present on retroviral particles. CONCLUSIONS: The results described here identify a novel mechanism through which IFITMs affect HIV-1 infectivity during the late phases of the viral life cycle. Put in the context of data obtained by other laboratories, these results indicate that IFITMs can target HIV at two distinct moments of its life cycle, in target cells as well as in virus-producing cells. These results raise the possibility that IFITMs could similarly affect distinct steps of the life cycle of a number of other viruses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12977-014-0103-y) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-25 /pmc/articles/PMC4251951/ /pubmed/25422070 http://dx.doi.org/10.1186/s12977-014-0103-y Text en © Tartour et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Tartour, Kevin
Appourchaux, Romain
Gaillard, Julien
Nguyen, Xuan-Nhi
Durand, Stéphanie
Turpin, Jocelyn
Beaumont, Elodie
Roch, Emmanuelle
Berger, Gregory
Mahieux, Renaud
Brand, Denys
Roingeard, Philippe
Cimarelli, Andrea
IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity
title IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity
title_full IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity
title_fullStr IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity
title_full_unstemmed IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity
title_short IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity
title_sort ifitm proteins are incorporated onto hiv-1 virion particles and negatively imprint their infectivity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251951/
https://www.ncbi.nlm.nih.gov/pubmed/25422070
http://dx.doi.org/10.1186/s12977-014-0103-y
work_keys_str_mv AT tartourkevin ifitmproteinsareincorporatedontohiv1virionparticlesandnegativelyimprinttheirinfectivity
AT appourchauxromain ifitmproteinsareincorporatedontohiv1virionparticlesandnegativelyimprinttheirinfectivity
AT gaillardjulien ifitmproteinsareincorporatedontohiv1virionparticlesandnegativelyimprinttheirinfectivity
AT nguyenxuannhi ifitmproteinsareincorporatedontohiv1virionparticlesandnegativelyimprinttheirinfectivity
AT durandstephanie ifitmproteinsareincorporatedontohiv1virionparticlesandnegativelyimprinttheirinfectivity
AT turpinjocelyn ifitmproteinsareincorporatedontohiv1virionparticlesandnegativelyimprinttheirinfectivity
AT beaumontelodie ifitmproteinsareincorporatedontohiv1virionparticlesandnegativelyimprinttheirinfectivity
AT rochemmanuelle ifitmproteinsareincorporatedontohiv1virionparticlesandnegativelyimprinttheirinfectivity
AT bergergregory ifitmproteinsareincorporatedontohiv1virionparticlesandnegativelyimprinttheirinfectivity
AT mahieuxrenaud ifitmproteinsareincorporatedontohiv1virionparticlesandnegativelyimprinttheirinfectivity
AT branddenys ifitmproteinsareincorporatedontohiv1virionparticlesandnegativelyimprinttheirinfectivity
AT roingeardphilippe ifitmproteinsareincorporatedontohiv1virionparticlesandnegativelyimprinttheirinfectivity
AT cimarelliandrea ifitmproteinsareincorporatedontohiv1virionparticlesandnegativelyimprinttheirinfectivity